View of Analysis and evaluation of the cost of the treatment anti-TNFalfa in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose.

Return to Article Details Analysis and evaluation of the cost of the treatment anti-TNFalfa in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose. Download Download PDF